Lynderm Research Inc. /ID# 153861

Markham, Ontario L3P 1X3

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) — Completed